Search Within

Qing Chang

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (4)
Groups
  1. Department of Pathology and Laboratory Medicine (12)
  2. Sloan Kettering Institute Postdocs (12)
  3. GSK Faculty (11)
  4. Human Oncology and Pathogenesis Program (9)
  5. Tow Center for Developmental Oncology (TCDO) (7)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)

More Groups

People
  1. Elisa De Stanchina (11)
  2. Marc Ladanyi (6)
  3. Inna Khodos (5)
  4. Romel Somwar (5)
  5. Marissa Mattar (4)
  6. Jacqueline Bromberg (3)

More People

Years
  1. 2023 (3)
  2. 2022 (6)
  3. 2020 (1)
  4. 2016 (1)
  5. 2011 (1)
Publications
  1. Nature Cancer (2)
  2. Cancer Discovery (1)
  3. European Journal of Cancer (1)
  4. Journal of Clinical Oncology (1)
  5. Journal of Thoracic Oncology (1)
  6. Molecular Cancer Research (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. Elsevier Inc. (2)
  3. Nature Publishing Group (2)
  4. Nature Research (2)
  5. American Association for the Advancement of Science (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
    Journal Article

    Miyazaki, I.; Odintsov, I.; Ishida, K.; Lui, A. J. W.; Kato, M.; Suzuki, T.; Zhang, T.; Wakayama, K.; Kurth, R. I.; Cheng, R.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
    Journal Article

    Chatila, W. K.; Walch, H.; Hechtman, J. F.; Moyer, S. M.; Sgambati, V.; Faleck, D. M.; Srivastava, A.; Tang, L.; Benhamida, J.; Ismailgeci, D.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Molecular characterization of acquired resistance to KRAS(G12C)–EGFR inhibition in colorectal cancer
    Journal Article

    Yaeger, R.; Mezzadra, R.; Sinopoli, J.; Bian, Y.; Marasco, M.; Kaplun, E.; Gao, H.; Zhao, H. Y.; Paula, A. D. C.; Zhu, Y.; more...
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Tractable patient-derived models for preclinical therapeutic studies of CNS metastases
    Meeting Abstract

    Vojnic, M.; Odintsov, I.; Offin, M. D.; Lui, A. J. W.; Khodos, I.; Chang, Q.; Mattar, M. S.; De Stanchina, E.; Ladanyi, M.; Somwar, R.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases
    Meeting Abstract

    Odintsov, I.; Lui, A. J. W.; Ishizawa, K.; Miyazaki, I.; Khodos, I.; Wakayama, K.; Vojnic, M.; Hagen, C. J.; Chang, Q.; Bonifacio, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Vepafestinib is effective in preclinical models of sarcomas with RET fusion including a brain metastasis model
    Meeting Abstract

    Odintsov, I.; Liu, A.; Khodos, I.; Chang, Q.; Giuliano, C.; Mattar, M.; Vojnic, M.; Bonifacio, A.; De Stanchina, E.; Lovati, E.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • TA0953/HM06, a novel RET-specific inhibitor effective in extracranial and CNS disease models of NSCLC with RETfusions
    Meeting Abstract

    Odintsov, I.; Lui, A. J. W.; Delasos, L.; Khodos, I.; Chang, Q.; Mattar, M. S.; Vojnic, M.; Lu, Y. C.; Kunte, S.; Bonifacio, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance
    Journal Article

    Strillacci, A.; Sansone, P.; Rajasekhar, V. K.; Turkekul, M.; Boyko, V.; Meng, F.; Houck-Loomis, B.; Brown, D.; Berger, M. F.; Hendrickson, R. C.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • KRAS mutants upregulate integrin β4 to promote invasion and metastasis in colorectal cancer
    Journal Article

    Choi, S. H.; Kim, J. K.; Chen, C. T.; Wu, C.; Marco, M. R.; Barriga, F. M.; O'Rourke, K.; Pelossof, R.; Qu, X.; Chang, Q.; more...
    Molecular Cancer Research (2022)

    Fulltext@MSK | Save
  • Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy
    Journal Article

    Samstein, R. M.; Krishna, C.; Ma, X.; Pei, X.; Lee, K. W.; Makarov, V.; Kuo, F.; Chung, J.; Srivastava, R. M.; Purohit, T. A.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save